BioCentury
ARTICLE | Clinical News

Adenovirus vector bearing the CFTR gene: Began a Phase I safety trial in up to 26 patients, using repeated dosing in the large airways of the lung. The trial is

March 27, 1995 8:00 AM UTC

GenVec, Rockville, Md. Product: Adenovirus vector bearing the CFTR gene Indication: Cystic fibrosis Status: Began a Phase I safety trial in up to 26 patients, using repeated dosing in the large airwa...